Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
D000328:Adult; D000368:Aged; D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D001011:Aorta; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D007269:Injections, Intra-Arterial; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000188:drug therapy*; D014226:Triazenes / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D014625:Vaginal Neoplasms / Q000188:drug therapy; D014846:Vulvar Neoplasms / Q000188:drug therapy
D000577:Amides; D000970:Antineoplastic Agents; D007093:Imidazoles; D014226:Triazenes